Abstract
Antibacterial resistance has recently been a huge burden on the pharmaceutical industry and a global threat to human’s health. Biofilm formation is a complex group of one or more microorganisms grouped together forming an extracellular polymeric substance (EPS) matrix that restricts the effectivity of antimicrobial compounds causing bacterial resistance infections. The discovery of new antibiofilm agents to serve us in the antibiotic pipeline is in huge demand as an increasing number of pathogenic bacteria are no longer responding to current antibiotics, resulting in less efficient treatment of infections. The marine environment is a novel source of thousands of natural products that possess various biological activities. Marine sponges are optimal sources for unique chemical scaffolding associated with symbiotic interactions. Marine sponges and their symbionts account for about 30% of the compounds discovered in the past few decades. This literature review will delve into fungal metabolites extracted from sponge-derived Aspergillus, Penicillium, and Fusarium from 2007 to 2022 covering their antibiotics and antibiofilm potentials. Metabolites collected from various locations could be unique to the collection location due to external factors, such as temperature, pH, salinity, and predators. This review chapter explores the impact of both geographical region and environmental conditions on secondary metabolite production and briefly outlines the current methods used for bioprospecting new antimicrobial agents. Current literature has shown the vast potential of sponge-derived fungal metabolites as potential novel antibiotics to combat the imminent threat of antibiotic resistance globally. Marine sponges are still relatively unexplored and have not been fully utilised as a latent source of new scaffolding and approaches to create novel antibiotics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdelaleem ER, Samy MN, Abdelmohsen UR, Desoukey SY (2022) Natural products potential of dictyoceratida sponges-associated micro-organisms. Lett Appl Microbiol 74(1):8–16
Al-Saleem MSM, Hassan WHB, El Sayed ZI, Abdel-Aal MM, Abdel-Mageed WM, Abdelsalam E, Abdelaziz S (2022) Metabolic profiling and in vitro assessment of the biological activities of the ethyl acetate extract of Penicillium chrysogenum “endozoic of Cliona sp. marine sponge” from the Red Sea (Egypt). Mar Drugs 20(5):326–349
Alves A, Cruz-Martins N, Rodrigues CF (2022) Marine compounds with anti-Candida sp. activity: a promised “land” for new antifungals. J Fungi (Basel) 8(7):669–679
Amelia TSM, Suaberon FC, Vad J, Fahmi ADM, Saludes JP, Bhubalan K (2022) Recent advances of marine sponge-associated microorganisms as a source of commercially viable natural products. Mar Biotechnol (NY) 24(3):492–512
Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673–683
Aslam B, Afzaal M, Sameen A, Khurshid M, Saeed F, Jabeen S, Aadil RM (2022) Microbial symbiotic implications in exploring novel antibiotics. In: Singh J, Sharma D (eds) Microbial resource technologies for sustainable development. Elsevier, London, pp 213–226
Asma ST, Imre K, Morar A, Herman V, Acaroz U, Mukhtar H, Arslan-Acaroz D, Shah SRA, Gerlach R (2022) An overview of biofilm formation-combating strategies and mechanisms of action of antibiofilm agents. Life (Basel) 12(8):1110–1141
Balakrishnan D, Kandasamy D, Nithyanand P (2014) A review on antioxidant activity of marine organisms. Int J ChemTech Res 6:3431–3436
Bayona LM, Van Leeuwen G, Erol Ö, Swierts T, Van Der Ent E, De Voogd NJ, Choi YH (2020) Influence of geographical location on the metabolic production of giant barrel sponges (Xestospongia spp.) revealed by metabolomics tools. ACS Omega 5(21):12398–12408
Brinkmann CM, Marker A, Kurtböke Dİ (2017) An overview on marine sponge-symbiotic bacteria as unexhausted sources for natural product discovery. Diversity 9(4):40–71
Browne AJ, Chipeta MG, Haines-Woodhouse G, Kumaran EPA, Hamadani BHK, Zaraa S, Henry NJ, Deshpande A, Reiner RC Jr, Day NPJ, Lopez AD, Dunachie S, Moore CE, Stergachis A, Hay SI, Dolecek C (2021) Global antibiotic consumption and usage in humans, 2000–2013;18: a spatial modelling study. Lancet Planet Health 5(12):e893–e904
Bugni TS, Ireland CM (2004) Marine-derived fungi: a chemically and biologically diverse group of microorganisms. Nat Prod Rep 21(1):143–163
Carrier TJ, Maldonado M, Schmittmann L, Pita L, Bosch TCG, Hentschel U (2022) Symbiont transmission in marine sponges: reproduction, development, and metamorphosis. BMC Biol 20(1):100–119
Chen H, Fujita M, Feng Q, Clardy J, Fink GR (2004) Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci U S A 101(14):5048–5052
Chen S, Liu D, Zhang Q, Guo P, Ding S, Shen J, Zhu K, Lin W (2021) A marine antibiotic kills multidrug-resistant bacteria without detectable high-level resistance. ACS Infect Dis 7(4):884–893
Cheng Z, Xu W, Liu L, Li S, Yuan W, Luo Z, Zhang J, Cheng Y, Li Q (2018) Peniginsengins B(−)E, new Farnesylcyclohexenones from the Deep Sea-derived fungus Penicillium sp. YPGA11. Mar Drugs 16(10):358–368
Cheng MM, Tang XL, Sun YT, Song DY, Cheng YJ, Liu H, Li PL, Li GQ (2020) Biological and chemical diversity of marine sponge-derived microorganisms over the last two decades from 1998 to 2017. Molecules 25(4):853–924
Courtenay M, Castro-Sanchez E, Fitzpatrick M, Gallagher R, Lim R, Morris G (2019) Tackling antimicrobial resistance 2019–2024—the UK’s five-year national action plan. J Hosp Infect 101(4):426–427
Cushnie TPT, Cushnie B, Echeverria J, Fowsantear W, Thammawat S, Dodgson JLA, Law S, Clow SM (2020) Bioprospecting for antibacterial drugs: a multidisciplinary perspective on natural product source material, bioassay selection and avoidable pitfalls. Pharm Res 37(7):125
Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2(2):114–122
Deng Y, Liu Y, Li J, Wang X, He S, Yan X, Shi Y, Zhang W, Ding L (2022) Marine natural products and their synthetic analogs as promising antibiofilm agents for antibiotics discovery and development. Eur J Med Chem 239:114513–114534
Doshi HK, Chua K, Kagda F, Tambyah PA (2011) Multi drug resistant pseudomonas infection in open fractures post definitive fixation leading to limb loss: a report of three cases. Int J Case Rep Images 2(5):1–6
Durães F, Szemerédi N, Kumla D, Pinto M, Kijjoa A, Spengler G, Sousa E (2021) Metabolites from marine-derived fungi as potential antimicrobial adjuvants. Mar Drugs 19(9):475–492
El-Bondkly AAM, El-Gendy MMAA, El-Bondkly AMA (2020) Construction of efficient recombinant strain through genome shuffling in marine endophytic Fusarium sp. ALAA-20 for improvement of lovastatin production using agro-industrial wastes. Arabian J Sci Eng 46(1):175–190
El-Bondkly EAM, El-Bondkly AAM, El-Bondkly AAM (2021) Marine endophytic fungal metabolites: a whole new world of pharmaceutical therapy exploration. Heliyon 7(3):e06362
Etebu E, Arikekpar I (2016) Antibiotics: classification and mechanisms of action with emphasis on molecular perspectives. Int J Appl Microbiol Biotechnol Res 4(2016):90–101
Evans ML, Gichana E, Zhou Y, Chapman MR (2018) Bacterial amyloids. Methods Mol Biol 1779:267–288
Fleming D, Rumbaugh KP (2017) Approaches to dispersing medical biofilms. Microorganisms 5(2):15–31
Flórez LV, Biedermann PHW, Engl T, Kaltenpoth M (2015) Defensive symbioses of animals with prokaryotic and eukaryotic microorganisms. Nat Prod Rep 32(7):904–936
Gomes NGM, Madureira-Carvalho A, Dias-Da-Silva D, Valentao P, Andrade PB (2021) Biosynthetic versatility of marine-derived fungi on the delivery of novel antibacterial agents against priority pathogens. Biomed Pharmacother 140:111756
Gupta RC, Srivastava A, Lall R (2018) Ochratoxins and citrinin. In: GUPTA RC (ed) Veterinary toxicology, 3rd edn. Academic Press, London
Hafez Ghoran S, Taktaz F, Ayatollahi SA, Kijjoa A (2022) Anthraquinones and their analogues from marine-derived fungi: chemistry and biological activities. Mar Drugs 20(8):474–543
Hancock REW, Alford MA, Haney EF (2021) Antibiofilm activity of host defence peptides: complexity provides opportunities. Nat Rev Microbiol 19(12):786–797
Hawkey PM (1998) The origins and molecular basis of antibiotic resistance. BMJ 317(7159):657–660
Hong L-L, Ding Y-F, Zhang W, Lin H-W (2022) Chemical and biological diversity of new natural products from marine sponges: a review (2009–2018). Mar Life Sci Technol 4(3):356–372
Ibrahim SRM, Mohamed GA, Khedr AIM (2017) Gamma-butyrolactones from Aspergillus species: structures, biosynthesis, and biological activities. Nat Prod Commun 12(5):791–800
Indraningrat AA, Smidt H, Sipkema D (2016) Bioprospecting sponge-associated microbes for antimicrobial compounds. Mar Drugs 14(5):87–153
Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA (2018) Bacterial biofilm and associated infections. J Chin Med Assoc 81(1):7–11
Jiang R, Pawliszyn J (2014) Cooled membrane for high sensitivity gas sampling. J Chromatogr A 1338:17–23
Jones EBG, Ramakrishna S, Vikineswary S, Das D, Bahkali AH, Guo SY, Pang KL (2022) How do fungi survive in the sea and respond to climate change? J Fungi (Basel) 8(3):291
Kaplan JB (2009) Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs 32(9):545–554
Karpinski TM (2019) Marine macrolides with antibacterial and/or antifungal activity. Mar Drugs 17(4):241–266
Karthikeyan A, Joseph A, Nair BG (2022) Promising bioactive compounds from the marine environment and their potential effects on various diseases. J Genet Eng Biotechnol 20(1):14
Khan M, Shamim S (2022) Understanding the mechanism of antimicrobial resistance and pathogenesis of salmonella enterica Serovar Typhi. Microorganisms 10(10):2006
Kiran GS, Sekar S, Ramasamy P, Thinesh T, Hassan S, Lipton AN, Ninawe AS, Selvin J (2018) Marine sponge microbial association: towards disclosing unique symbiotic interactions. Mar Environ Res 140:169–179
Koch L, Lodin A, Herold I, Ilan M, Carmeli S, Yarden O (2014) Sensitivity of Neurospora crassa to a marine-derived Aspergillus tubingensis anhydride exhibiting antifungal activity that is mediated by the MAS1 protein. Mar Drugs 12(9):4713–4731
Kong C, Huang H, Xue Y, Liu Y, Peng Q, Liu Q, Xu Q, Zhu Q, Yin Y, Zhou X, Zhang Y, Cai M (2018) Heterologous pathway assembly reveals molecular steps of fungal terreic acid biosynthesis. Sci Rep 8(1):2116–2128
Koopmans M, Martens D, Wijffels RH (2009) Towards commercial production of sponge medicines. Mar Drugs 7(4):787–802
Kostakioti M, Hadjifrangiskou M, Hultgren SJ (2013) Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med 3(4):a010306–a010330
Kuml D, Dethoup T, Buttachon S, Singburaudom N, Silva AM, Kijjoa A (2014) Spiculisporic acid E, a new spiculisporic acid derivative and ergosterol derivatives from the marine-sponge associated fungus Talaromyces trachyspermus (KUFA 0021). Nat Prod Commun 9(8):1147–1150
Kumla D, Dethoup T, Gales L, Pereira JA, Freitas-Silva J, Costa PM, Silva AMS, Pinto MMM, Kijjoa A (2019) Erubescensoic acid, a new Polyketide and a Xanthonopyrone SPF-3059-26 from the culture of the marine sponge-associated fungus Penicillium erubescens KUFA 0220 and antibacterial activity evaluation of some of its constituents. Molecules 24(1):208
Lebeaux D, Ghigo JM, Beloin C (2014) Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78(3):510–543
Lee YM, Li H, Hong J, Cho HY, Bae KS, Kim MA, Kim DK, Jung JH (2010) Bioactive metabolites from the sponge-derived fungus Aspergillus versicolor. Arch Pharm Res 33(2):231–235
Lee YJ, Cho Y, Tran HNK (2021) Secondary metabolites from the marine sponges of the genus Petrosia: a literature review of 43 years of research. Mar Drugs 19(3):122
Levitus M, Rewane A, Perera TB (2022) Vancomycin-resistant enterococci. In: StatPearls. StatPearls Publishing, Treasure Island, FL
Li Z (2009) Advances in marine symbiotic cyanobacteria. In: Gault PM, Marler HJ (eds) Handbook on cyanobacteria: biochemistry, biotechnology and applications. Nova Science, New York, pp 464–472
Li XH, Lee JH (2017) Antibiofilm agents: a new perspective for antimicrobial strategy. J Microbiol 55(10):753–766
Li D, Xu Y, Shao C-L, Yang R-Y, Zheng C-J, Chen Y-Y, Fu X-M, Qian P-Y, She Z-G, Voogd NJD, Wang C-Y (2012) Antibacterial bisabolane-type sesquiterpenoids from the sponge-derived fungus Aspergillus sp. Mar Drugs 10(1):234–241
Li H, Maimaitiming M, Zhou Y, Li H, Wang P, Liu Y, Schaberle TF, Liu Z, Wang CY (2022a) Discovery of marine natural products as promising antibiotics against Pseudomonas aeruginosa. Mar Drugs 20(3):192
Li Q, Mao S, Wang H, Ye X (2022b) The molecular architecture of Pseudomonas aeruginosa quorum-sensing inhibitors. Mar Drugs 20(8):488
Lin W, Brauers G, Ebel R, Wray V, Berg A, Sudarsono, Proksch P (2003) Novel chromone derivatives from the fungus Aspergillus versicolor isolated from the marine sponge Xestospongia exigua. J Nat Prod 66(1):57–61
Lindequist U (2016) Marine-derived pharmaceuticals—challenges and opportunities. Biomol Ther (Seoul) 24(6):561–571
Liu S, Dai H, Konuklugil B, Orfali RS, Lin W, Kalscheuer R, Liu Z, Proksch P (2016) Phenolic bisabolanes from the sponge-derived fungus Aspergillus sp. Phytochem Lett 18:187–191
Liu Y, Ding L, Fang F, He S (2019) Penicillilactone a, a novel antibacterial 7-membered lactone derivative from the sponge-associated fungus Penicillium sp. LS54. Nat Prod Res 33(17):2466–2470
Lopanik NB (2014) Chemical defensive symbioses in the marine environment. Funct Ecol 28(2):328–340
Luo Y, Song Y (2021) Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities. Int J Mol Sci 22(21):11401–11421
Ma H, Bryers JD (2013) Non-invasive determination of conjugative transfer of plasmids bearing antibiotic-resistance genes in biofilm-bound bacteria: effects of substrate loading and antibiotic selection. Appl Microbiol Biotechnol 97(1):317–328
Ma HG, Liu Q, Zhu GL, Liu HS, Zhu WM (2016) Marine natural products sourced from marine-derived Penicillium fungi. J Asian Nat Prod Res 18(1):92–115
Mattarelli P, Sgorbati B (2018) Chemotaxonomic features in the bifidobacteriaceae family. In: Mattarelli P, Biavati B, Holzapfel WH, Wood BJB (eds) The bifidobacteria and related organisms. Academic Press, London
Mayer AMS, Rodriguez AD, Taglialatela-Scafati O, Fusetani N (2017) Marine pharmacology in 2012–2013: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar Drugs 15(9):273
Moitinho-Silva L, Nielsen S, Amir A, Gonzalez A, Ackermann GL, Cerrano C, Astudillo-Garcia C, Easson C, Sipkema D, Liu F, Steinert G, Kotoulas G, Mccormack GP, Feng G, Bell JJ, Vicente J, Bjork JR, Montoya JM, Olson JB, Reveillaud J, Steindler L, Pineda MC, Marra MV, Ilan M, Taylor MW, Polymenakou P, Erwin PM, Schupp PJ, Simister RL, Knight R, Thacker RW, Costa R, Hill RT, Lopez-Legentil S, Dailianis T, Ravasi T, Hentschel U, Li Z, Webster NS, Thomas T (2017) The sponge microbiome project. Gigascience 6(10):1–7
Mosadeghzad Z, Zakaria Z, Asmat A, Gires U, Wickneswari R, Pittayakhajonwut P, Farahani G (2012) Chemical components of marine sponge derived fungus Fusarium proliferatum collected from Pulau Tinggi, Malaysia. Sains Malays 41:333–337
Nadar S, Khan T, Patching SG, Omri A (2022) Development of antibiofilm therapeutics strategies to overcome antimicrobial drug resistance. Microorganisms 10(2):303–331
Nicoletti R, Trincone A (2016) Bioactive compounds produced by strains of Penicillium and Talaromyces of marine origin. Mar Drugs 14(2):37
Oladipo A, Enwemiwe V, Ejeromedoghene O, Adebayo A, Ogunyemi O, Fu F (2022) Production and functionalities of specialized metabolites from different organic sources. Meta 12(6):534
Oulhen N, Schulz BJ, Carrier TJ (2016) English translation of Heinrich Anton de Bary’s 1878 speech, ‘die Erscheinung der Symbiose’ (‘De la symbiose’). Symbiosis 69(3):131–139
Pang X, Cai G, Lin X, Salendra L, Zhou X, Yang B, Wang J, Wang J, Xu S, Liu Y (2019) New alkaloids and polyketides from the marine sponge-derived fungus Penicillium sp. SCSIO41015. Mar Drugs 17(7):398
Parrino B, Schillaci D, Carnevale I, Giovannetti E, Diana P, Cirrincione G, Cascioferro S (2019) Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance. Eur J Med Chem 161:154–178
Petrini O, Sieber TN, Toti L, Viret O (1993) Ecology, metabolite production, and substrate utilization in endophytic fungi. Nat Toxins 1(3):185–196
Pita L, Rix L, Slaby BM, Franke A, Hentschel U (2018) The sponge holobiont in a changing ocean: from microbes to ecosystems. Microbiome 6(46):1–18
Pompilio A, Scocchi M, Mangoni ML, Shirooie S, Serio A, Ferreira Garcia Da Costa Y, Alves MS, Seker Karatoprak G, Suntar I, Khan H, Di Bonaventura G (2022) Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? Crit Rev Microbiol 49:117–149
Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109(7):309–318
Prompanya C, Dethoup T, Bessa LJ, Pinto MM, Gales L, Costa PM, Silva AM, Kijjoa A (2014) New isocoumarin derivatives and meroterpenoids from the marine sponge-associated fungus Aspergillus similanensis sp. Nov. KUFA 0013. Mar Drugs 12(10):5160–5173
Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, Mcnamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41–58
Raheem N, Straus SK (2019) Mechanisms of action for antimicrobial peptides with antibacterial and Antibiofilm functions. Front Microbiol 10:2866
Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4(3):482–501
Rodrigues AG (2016) Secondary metabolism and antimicrobial metabolites of Aspergillus. In: Gupta VK (ed) New and future developments in microbial biotechnology and bioengineering. Elsevier, Amsterdam, pp 81–93
Roy R, Tiwari M, Donelli G, Tiwari V (2018) Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence 9(1):522–554
Sabdaningsih A, Liu Y, Mettal U, Heep J, Riyanti, Wang L, Cristianawati O, Nuryadi H, Triandala Sibero M, Marner M, Radjasa OK, Sabdono A, Trianto A, Schaberle TF (2020) A new citrinin derivative from the Indonesian marine sponge-associated fungus Penicillium citrinum. Mar Drugs 18(4):227
San-Martin A, Rovirosa J, Vaca I, Vergara K, Acevedo L, Viña D, Orallo F, Chamy MC (2011) New butyrlactone from a marine-derived fungus Aspergillus sp. J Chil Chem Soc 56:625–627
Schönberg C (2016) Effects of dredging on filter feeder communities, with a focus on sponges report of theme, 127
Shaala LA, Alzughaibi T, Genta-Jouve G, Youssef DTA (2021) Fusaripyridines a and B; highly oxygenated antimicrobial alkaloid dimers featuring an unprecedented 1,4-bis(2-hydroxy-1,2-dihydropyridin-2-yl)butane-2,3-dione core from the marine fungus Fusarium sp. LY019. Mar Drugs 19(9):505–515
Shah M, Sun C, Sun Z, Zhang G, Che Q, Gu Q, Zhu T, Li D (2020) Antibacterial polyketides from antarctica sponge-derived fungus Penicillium sp. HDN151272. Mar Drugs 18(2):71
Sharma D, Misba L, Khan AU (2019) Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control 8(1):76–86
Sibero MT, Zhou T, Fukaya K, Urabe D, Radjasa OKK, Sabdono A, Trianto A, Igarashi Y (2019) Two new aromatic polyketides from a sponge-derived Fusarium. Beilstein J Org Chem 15:2941–2947
Singh L, Cariappa MP, Kaur M (2016) Klebsiella oxytoca: an emerging pathogen? Med J Armed Forces India 72:S59–S61
Singh S, Singh SK, Chowdhury I, Singh R (2017) Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. Open Microbiol J 11:53–62
Steffen K, Indraningrat AG, Erngren I, Haglöf J, Becking LE, Smidt H, Yashayaev I, Kenchington E, Pettersson C, Cárdenas P, Sipkema D (2022) Oceanographic setting influences the prokaryotic community and metabolome in deep-sea sponges. Sci Rep 12(1):3356
Stewart PS, William Costerton J (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358(9276):135–138
Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, Cavanagh J (2011) Anti-biofilm compounds derived from marine sponges. Mar Drugs 9(10):2010–2035
Tagliabue A, Rappuoli R (2018) Changing priorities in vaccinology: antibiotic resistance moving to the top. Front Immunol 9:1068
Taylor MW, Radax R, Steger D, Wagner M (2007) Sponge-associated microorganisms: evolution, ecology, and biotechnological potential. Microbiol Mol Biol Rev 71(2):295–347
Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S (2011) Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013(1):CD004816
Teixeira-Santos R, Gomes LC, Mergulhão FJM (2022) Recent advances in antimicrobial surfaces for urinary catheters. Curr Opin Biomed Eng 22:100394–100406
Toghueo RMK, Boyom FF (2020) Endophytic Penicillium species and their agricultural, biotechnological, and pharmaceutical applications. 3 Biotech 10(3):107
Varijakzhan D, Loh JY, Yap WS, Yusoff K, Seboussi R, Lim SE, Lai KS, Chong CM (2021) Bioactive compounds from marine sponges: fundamentals and applications. Mar Drugs 19(5):246
Visamsetti A, Ramachandran SS, Kandasamy D (2016) Penicillium chrysogenum DSOA associated with marine sponge (Tedania anhelans) exhibit antimycobacterial activity. Microbiol Res 185:55–60
Wang Y, Wang L, Liu F, Wang Q, Selvaraj JN, Xing F, Zhao Y, Liu Y (2016) Ochratoxin a producing fungi, biosynthetic pathway and regulatory mechanisms. Toxins 8(3):83–98
Weigelt MA, Mcnamara SA, Sanchez D, Hirt PA, Kirsner RS (2021) Evidence-based review of antibiofilm agents for wound care. Adv Wound Care (New Rochelle) 10(1):13–23
Wiese J, Ohlendorf B, Blumel M, Schmaljohann R, Imhoff JF (2011) Phylogenetic identification of fungi isolated from the marine sponge Tethya aurantium and identification of their secondary metabolites. Mar Drugs 9(4):561–585
Wilbur SL, Marchlinski FE (1997) Adenosine as an antiarrhythmic agent. Am J Cardiol 79(12):30–37
Wong Chin JM, Puchooa D, Bahorun T, Jeewon R (2021) Antimicrobial properties of marine fungi from sponges and brown algae of Mauritius. Mycology 12(4):231–244
Xu M-J, Zhong L-J, Chen J-K, Bu Q, Liang L-F (2022) Secondary metabolites from marine sponges of the genus Oceanapia: chemistry and biological activities. Mar Drugs 20(2):144–160
Yu X, Li L, Sun S, Chang A, Dai X, Li H, Wang Y, Zhu H (2021) A cyclic dipeptide from marine fungus Penicillium Chrysogenum DXY-1 exhibits anti-quorum sensing activity. ACS Omega 6(11):7693–7700
Zhang M, Wang M, Zhu X, Yu W, Gong Q (2018) Equisetin as potential quorum sensing inhibitor of Pseudomonas aeruginosa. Biotechnol Lett 40(5):865–870
Zhang P, Wei Q, Yuan X, Xu K (2020) Newly reported alkaloids produced by marine-derived Penicillium species (covering 2014–2018). Bioorg Chem 99:103840
Zhang S, Song W, Nothias LF, Couvillion SP, Webster N, Thomas T (2022) Comparative metabolomic analysis reveals shared and unique chemical interactions in sponge holobionts. Microbiome 10(1):22
Zhou Y, Debbab A, Wray V, Lin W, Schulz B, Trepos R, Pile C, Hellio C, Proksch P, Aly AH (2014) Marine bacterial inhibitors from the sponge-derived fungus Aspergillus sp. Tetrahedron Lett 55(17):2789–2792
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Edrada-Ebel, R., Michael, A., Alsaleh, F., Zaharuddin, H.B. (2024). Antibiofilm Metabolites from Sponge-Derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline. In: Deshmukh, S.K., Takahashi, J.A., Saxena, S. (eds) Fungi Bioactive Metabolites. Springer, Singapore. https://doi.org/10.1007/978-981-99-5696-8_6
Download citation
DOI: https://doi.org/10.1007/978-981-99-5696-8_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-5695-1
Online ISBN: 978-981-99-5696-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)